---
title: "HealthEquity, Inc. Stock 12‑Month Price Target Raised to $114.56, Implies 27% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288107951.md"
description: "HealthEquity, Inc.'s average 12-month price target was raised to $114.12 by 16 analysts, implying a 26% upside from the May 28 close. The consensus rating remains 'Buy' among 17 covering analysts (16 Buys, 1 Sell). Price forecasts range from $88 to $128 per share."
datetime: "2026-05-29T19:20:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288107951.md)
  - [en](https://longbridge.com/en/news/288107951.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288107951.md)
generator: "portal-rs"
---

# HealthEquity, Inc. Stock 12‑Month Price Target Raised to $114.56, Implies 27% Upside

-   According to estimates from 16 analysts, HealthEquity, Inc. stock's average price target has risen from $113 to $114.12, with forecasts ranging from $88 to $128 per share
-   Based on the May 28 closing price, the updated target implies approximately 26% potential upside
-   Consensus rating remains at “Buy” across 17 covering analysts, with 16 Buys, 0 Holds and 1 Sells

Explore more price target data and ratings for HealthEquity, Inc. on the , and track all previous and future analyst recommendations for HealthEquity, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [HQY.US](https://longbridge.com/en/quote/HQY.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Wellington Management Group LLP Reduces Position in HealthEquity, Inc. $HQY](https://longbridge.com/en/news/298105319.md)
- [Does HealthEquity's (HQY) Upgraded Outlook and Buybacks Reveal a New Capital Allocation Playbook?](https://longbridge.com/en/news/297694505.md)
- [Apnimed, Inc. reports Q2 results](https://longbridge.com/en/news/298366495.md)
- [Does Toro (TTC) Prioritizing Productivity Gains Hint At A Deeper Shift In Its Profit Playbook?](https://longbridge.com/en/news/298119884.md)
- [Braveheart Bio, Inc. reports Q2 results](https://longbridge.com/en/news/298361396.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**